End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.18 CNY | +2.61% |
|
+0.45% | +9.05% |
06-28 | Livzon Pharmaceutical Group Cancels Repurchased Shares | MT |
06-20 | India's Biocon seeks partner to test generic Wegovy, Ozempic in China | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.05% | 4.25B | |
+54.25% | 823B | |
+42.31% | 641B | |
-6.65% | 352B | |
+16.85% | 324B | |
+8.10% | 301B | |
+14.00% | 241B | |
+1.84% | 223B | |
+13.51% | 218B | |
+7.66% | 167B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- China Grants Nod to Livzon Pharmaceutical Subsidiary's Clinical Trials for SARS-CoV-2 Booster Shot